Jones David Scott
EyePoint Pharmaceuticals, Inc. · SVP & Chief Commercial Officer
David Scott Jones serves as the Senior Vice President and Chief Commercial Officer at EyePoint Pharmaceuticals, Inc., a company focused on innovative ophthalmic therapeutics. His recent trading activity, as disclosed in SEC Form 4 filings, reflects a series of sale transactions with a notable concentration on EyePoint Pharmaceuticals (EYPT). Between January 24, 2024, and February 13, 2024, he reported 10 sales, with the largest transaction valued at approximately $652.3K, demonstrating a clear pattern of divestment during this period.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $418k16.4k shares | SellJan 26, 2024 | $25.45 | $13.04 | |
| $243k9.6k shares | SellJan 26, 2024 | $25.27 | $13.04 | |
| $7.5k300 shares | SellJan 25, 2024 | $25.00 | $13.04 | |
| $143k5.7k shares | SellJan 24, 2024 | $25.01 | $13.04 | |
| $140k5.6k shares | SellJan 24, 2024 | $25.01 | $13.04 | |
| $13k500 shares | SellJan 23, 2024 | $25.00 | $13.04 | |
| $10k400 shares | SellJan 23, 2024 | $25.00 | $13.04 | |
| $652k28.8k shares | SellJan 22, 2024 | $22.69 | $13.04 | |
| $120k5.4k shares | SellJan 22, 2024 | $22.24 | $13.04 |